ginkgolide b has been researched along with Cognitive Dysfunction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, Y; Liu, J; Sun, J; Ye, T; Zhang, R; Zhang, Y | 1 |
| Hao, YN; Huang, X; Lin, DD; Luo, T; Wu, AS | 1 |
| Hao, Y; Huang, P; Lin, D; Luo, T; Shen, W; Shi, R; Wei, C; Wu, A | 1 |
3 other study(ies) available for ginkgolide b and Cognitive Dysfunction
| Article | Year |
|---|---|
Protective Effect of Ginkgolide B against Cognitive Impairment in Mice via Regulation of Gut Microbiota.
Topics: Animals; Cognitive Dysfunction; Gastrointestinal Microbiome; Ginkgolides; Lactones; Male; Mice; RNA, Ribosomal, 16S | 2021 |
Ginkgolide B improved postoperative cognitive dysfunction by inhibiting microgliosis-mediated neuroinflammation in the hippocampus of mice.
Topics: Animals; Cognitive Dysfunction; Ginkgolides; Hippocampus; Lactones; Mice; Neuroinflammatory Diseases; Postoperative Cognitive Complications; Postoperative Complications; Rats | 2022 |
Ginkgolide B‑mediated therapeutic effects on perioperative neurocognitive dysfunction are associated with the inhibition of iNOS‑mediated production of NO.
Topics: Animals; Apoptosis; Cognitive Dysfunction; Disease Models, Animal; Ginkgolides; Hippocampus; Lactones; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neurocognitive Disorders; Nitric Oxide; Nitric Oxide Synthase Type II; Superoxide Dismutase; Therapeutics; Up-Regulation | 2021 |